United States · FDA National Drug Code directory
BLIP
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 82966-734_ec193206-c031-4e16-b131-17444db251f3
- Product NDC
- 82966-734
- Form
- LOZENGE
- Composition / generic term
- Nicotine Polacrilex
- Labeler
- Blip Products, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250617
- Source listing expiry
- 20271231
Source-listed ingredients
- NICOTINE — 2 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 CONTAINER in 1 CARTON (82966-734-01) / 27 LOZENGE in 1 CONTAINER · 82966-734-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →